Global Pancreatic Beta-Cell Protection Market Insights and Forecast to 2028

Report ID: 1548873 | Published Date: Jan 2025 | No. of Page: 117 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Pancreatic Beta-Cell Protection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Stem Cell Based
        1.2.3 Gene Therapies
        1.2.4 RNA Based Therapies
        1.2.5 Monoclonal Antibodies (MAbs)
        1.2.6 Phytotherapy
    1.3 Market by Application
        1.3.1 Global Pancreatic Beta-Cell Protection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Medical Research Laboratory
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Pancreatic Beta-Cell Protection Market Perspective (2017-2028)
    2.2 Pancreatic Beta-Cell Protection Growth Trends by Region
        2.2.1 Pancreatic Beta-Cell Protection Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Pancreatic Beta-Cell Protection Historic Market Size by Region (2017-2022)
        2.2.3 Pancreatic Beta-Cell Protection Forecasted Market Size by Region (2023-2028)
    2.3 Pancreatic Beta-Cell Protection Market Dynamics
        2.3.1 Pancreatic Beta-Cell Protection Industry Trends
        2.3.2 Pancreatic Beta-Cell Protection Market Drivers
        2.3.3 Pancreatic Beta-Cell Protection Market Challenges
        2.3.4 Pancreatic Beta-Cell Protection Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Pancreatic Beta-Cell Protection Players by Revenue
        3.1.1 Global Top Pancreatic Beta-Cell Protection Players by Revenue (2017-2022)
        3.1.2 Global Pancreatic Beta-Cell Protection Revenue Market Share by Players (2017-2022)
    3.2 Global Pancreatic Beta-Cell Protection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Pancreatic Beta-Cell Protection Revenue
    3.4 Global Pancreatic Beta-Cell Protection Market Concentration Ratio
        3.4.1 Global Pancreatic Beta-Cell Protection Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Pancreatic Beta-Cell Protection Revenue in 2021
    3.5 Pancreatic Beta-Cell Protection Key Players Head office and Area Served
    3.6 Key Players Pancreatic Beta-Cell Protection Product Solution and Service
    3.7 Date of Enter into Pancreatic Beta-Cell Protection Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Pancreatic Beta-Cell Protection Breakdown Data by Type
    4.1 Global Pancreatic Beta-Cell Protection Historic Market Size by Type (2017-2022)
    4.2 Global Pancreatic Beta-Cell Protection Forecasted Market Size by Type (2023-2028)
5 Pancreatic Beta-Cell Protection Breakdown Data by Application
    5.1 Global Pancreatic Beta-Cell Protection Historic Market Size by Application (2017-2022)
    5.2 Global Pancreatic Beta-Cell Protection Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Pancreatic Beta-Cell Protection Market Size (2017-2028)
    6.2 North America Pancreatic Beta-Cell Protection Market Size by Type
        6.2.1 North America Pancreatic Beta-Cell Protection Market Size by Type (2017-2022)
        6.2.2 North America Pancreatic Beta-Cell Protection Market Size by Type (2023-2028)
        6.2.3 North America Pancreatic Beta-Cell Protection Market Share by Type (2017-2028)
    6.3 North America Pancreatic Beta-Cell Protection Market Size by Application
        6.3.1 North America Pancreatic Beta-Cell Protection Market Size by Application (2017-2022)
        6.3.2 North America Pancreatic Beta-Cell Protection Market Size by Application (2023-2028)
        6.3.3 North America Pancreatic Beta-Cell Protection Market Share by Application (2017-2028)
    6.4 North America Pancreatic Beta-Cell Protection Market Size by Country
        6.4.1 North America Pancreatic Beta-Cell Protection Market Size by Country (2017-2022)
        6.4.2 North America Pancreatic Beta-Cell Protection Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Pancreatic Beta-Cell Protection Market Size (2017-2028)
    7.2 Europe Pancreatic Beta-Cell Protection Market Size by Type
        7.2.1 Europe Pancreatic Beta-Cell Protection Market Size by Type (2017-2022)
        7.2.2 Europe Pancreatic Beta-Cell Protection Market Size by Type (2023-2028)
        7.2.3 Europe Pancreatic Beta-Cell Protection Market Share by Type (2017-2028)
    7.3 Europe Pancreatic Beta-Cell Protection Market Size by Application
        7.3.1 Europe Pancreatic Beta-Cell Protection Market Size by Application (2017-2022)
        7.3.2 Europe Pancreatic Beta-Cell Protection Market Size by Application (2023-2028)
        7.3.3 Europe Pancreatic Beta-Cell Protection Market Share by Application (2017-2028)
    7.4 Europe Pancreatic Beta-Cell Protection Market Size by Country
        7.4.1 Europe Pancreatic Beta-Cell Protection Market Size by Country (2017-2022)
        7.4.2 Europe Pancreatic Beta-Cell Protection Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Size (2017-2028)
    8.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type
        8.2.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Pancreatic Beta-Cell Protection Market Share by Type (2017-2028)
    8.3 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application
        8.3.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Pancreatic Beta-Cell Protection Market Share by Application (2017-2028)
    8.4 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region
        8.4.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Pancreatic Beta-Cell Protection Market Size (2017-2028)
    9.2 Latin America Pancreatic Beta-Cell Protection Market Size by Type
        9.2.1 Latin America Pancreatic Beta-Cell Protection Market Size by Type (2017-2022)
        9.2.2 Latin America Pancreatic Beta-Cell Protection Market Size by Type (2023-2028)
        9.2.3 Latin America Pancreatic Beta-Cell Protection Market Share by Type (2017-2028)
    9.3 Latin America Pancreatic Beta-Cell Protection Market Size by Application
        9.3.1 Latin America Pancreatic Beta-Cell Protection Market Size by Application (2017-2022)
        9.3.2 Latin America Pancreatic Beta-Cell Protection Market Size by Application (2023-2028)
        9.3.3 Latin America Pancreatic Beta-Cell Protection Market Share by Application (2017-2028)
    9.4 Latin America Pancreatic Beta-Cell Protection Market Size by Country
        9.4.1 Latin America Pancreatic Beta-Cell Protection Market Size by Country (2017-2022)
        9.4.2 Latin America Pancreatic Beta-Cell Protection Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Pancreatic Beta-Cell Protection Market Size (2017-2028)
    10.2 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type
        10.2.1 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Pancreatic Beta-Cell Protection Market Share by Type (2017-2028)
    10.3 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application
        10.3.1 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Pancreatic Beta-Cell Protection Market Share by Application (2017-2028)
    10.4 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country
        10.4.1 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 ViaCyte
        11.1.1 ViaCyte Company Details
        11.1.2 ViaCyte Business Overview
        11.1.3 ViaCyte Pancreatic Beta-Cell Protection Introduction
        11.1.4 ViaCyte Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
        11.1.5 ViaCyte Recent Developments
    11.2 PharmaCyte Biotech
        11.2.1 PharmaCyte Biotech Company Details
        11.2.2 PharmaCyte Biotech Business Overview
        11.2.3 PharmaCyte Biotech Pancreatic Beta-Cell Protection Introduction
        11.2.4 PharmaCyte Biotech Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
        11.2.5 PharmaCyte Biotech Recent Developments
    11.3 Boehringer Ingelheim
        11.3.1 Boehringer Ingelheim Company Details
        11.3.2 Boehringer Ingelheim Business Overview
        11.3.3 Boehringer Ingelheim Pancreatic Beta-Cell Protection Introduction
        11.3.4 Boehringer Ingelheim Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
        11.3.5 Boehringer Ingelheim Recent Developments
    11.4 GalaxoSmithKline
        11.4.1 GalaxoSmithKline Company Details
        11.4.2 GalaxoSmithKline Business Overview
        11.4.3 GalaxoSmithKline Pancreatic Beta-Cell Protection Introduction
        11.4.4 GalaxoSmithKline Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
        11.4.5 GalaxoSmithKline Recent Developments
    11.5 Beta-Cell NV
        11.5.1 Beta-Cell NV Company Details
        11.5.2 Beta-Cell NV Business Overview
        11.5.3 Beta-Cell NV Pancreatic Beta-Cell Protection Introduction
        11.5.4 Beta-Cell NV Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
        11.5.5 Beta-Cell NV Recent Developments
    11.6 Novartis
        11.6.1 Novartis Company Details
        11.6.2 Novartis Business Overview
        11.6.3 Novartis Pancreatic Beta-Cell Protection Introduction
        11.6.4 Novartis Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
        11.6.5 Novartis Recent Developments
    11.7 Janssen Research & Development
        11.7.1 Janssen Research & Development Company Details
        11.7.2 Janssen Research & Development Business Overview
        11.7.3 Janssen Research & Development Pancreatic Beta-Cell Protection Introduction
        11.7.4 Janssen Research & Development Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
        11.7.5 Janssen Research & Development Recent Developments
    11.8 Pfizer Inc
        11.8.1 Pfizer Inc Company Details
        11.8.2 Pfizer Inc Business Overview
        11.8.3 Pfizer Inc Pancreatic Beta-Cell Protection Introduction
        11.8.4 Pfizer Inc Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
        11.8.5 Pfizer Inc Recent Developments
    11.9 BioLineRx
        11.9.1 BioLineRx Company Details
        11.9.2 BioLineRx Business Overview
        11.9.3 BioLineRx Pancreatic Beta-Cell Protection Introduction
        11.9.4 BioLineRx Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
        11.9.5 BioLineRx Recent Developments
    11.10 Genentech
        11.10.1 Genentech Company Details
        11.10.2 Genentech Business Overview
        11.10.3 Genentech Pancreatic Beta-Cell Protection Introduction
        11.10.4 Genentech Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
        11.10.5 Genentech Recent Developments
    11.11 Novo Nordisk
        11.11.1 Novo Nordisk Company Details
        11.11.2 Novo Nordisk Business Overview
        11.11.3 Novo Nordisk Pancreatic Beta-Cell Protection Introduction
        11.11.4 Novo Nordisk Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
        11.11.5 Novo Nordisk Recent Developments
    11.12 Sanofi
        11.12.1 Sanofi Company Details
        11.12.2 Sanofi Business Overview
        11.12.3 Sanofi Pancreatic Beta-Cell Protection Introduction
        11.12.4 Sanofi Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
        11.12.5 Sanofi Recent Developments
    11.13 Osiris Therapeutics
        11.13.1 Osiris Therapeutics Company Details
        11.13.2 Osiris Therapeutics Business Overview
        11.13.3 Osiris Therapeutics Pancreatic Beta-Cell Protection Introduction
        11.13.4 Osiris Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
        11.13.5 Osiris Therapeutics Recent Developments
    11.14 Beta-O2 Technologies Ltd
        11.14.1 Beta-O2 Technologies Ltd Company Details
        11.14.2 Beta-O2 Technologies Ltd Business Overview
        11.14.3 Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Introduction
        11.14.4 Beta-O2 Technologies Ltd Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
        11.14.5 Beta-O2 Technologies Ltd Recent Developments
    11.15 Transition Therapeutics
        11.15.1 Transition Therapeutics Company Details
        11.15.2 Transition Therapeutics Business Overview
        11.15.3 Transition Therapeutics Pancreatic Beta-Cell Protection Introduction
        11.15.4 Transition Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2017-2022)
        11.15.5 Transition Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Pancreatic Beta-Cell Protection Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Stem Cell Based
    Table 3. Key Players of Gene Therapies
    Table 4. Key Players of RNA Based Therapies
    Table 5. Key Players of Monoclonal Antibodies (MAbs)
    Table 6. Key Players of Phytotherapy
    Table 7. Global Pancreatic Beta-Cell Protection Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global Pancreatic Beta-Cell Protection Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Pancreatic Beta-Cell Protection Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Pancreatic Beta-Cell Protection Market Share by Region (2017-2022)
    Table 11. Global Pancreatic Beta-Cell Protection Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Pancreatic Beta-Cell Protection Market Share by Region (2023-2028)
    Table 13. Pancreatic Beta-Cell Protection Market Trends
    Table 14. Pancreatic Beta-Cell Protection Market Drivers
    Table 15. Pancreatic Beta-Cell Protection Market Challenges
    Table 16. Pancreatic Beta-Cell Protection Market Restraints
    Table 17. Global Pancreatic Beta-Cell Protection Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Pancreatic Beta-Cell Protection Revenue Share by Players (2017-2022)
    Table 19. Global Top Pancreatic Beta-Cell Protection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pancreatic Beta-Cell Protection as of 2021)
    Table 20. Ranking of Global Top Pancreatic Beta-Cell Protection Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Pancreatic Beta-Cell Protection Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Pancreatic Beta-Cell Protection Product Solution and Service
    Table 24. Date of Enter into Pancreatic Beta-Cell Protection Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Pancreatic Beta-Cell Protection Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type (2017-2022)
    Table 28. Global Pancreatic Beta-Cell Protection Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type (2023-2028)
    Table 30. Global Pancreatic Beta-Cell Protection Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Pancreatic Beta-Cell Protection Revenue Share by Application (2017-2022)
    Table 32. Global Pancreatic Beta-Cell Protection Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Pancreatic Beta-Cell Protection Revenue Share by Application (2023-2028)
    Table 34. North America Pancreatic Beta-Cell Protection Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America Pancreatic Beta-Cell Protection Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America Pancreatic Beta-Cell Protection Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America Pancreatic Beta-Cell Protection Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America Pancreatic Beta-Cell Protection Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America Pancreatic Beta-Cell Protection Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe Pancreatic Beta-Cell Protection Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe Pancreatic Beta-Cell Protection Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe Pancreatic Beta-Cell Protection Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe Pancreatic Beta-Cell Protection Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe Pancreatic Beta-Cell Protection Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe Pancreatic Beta-Cell Protection Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Pancreatic Beta-Cell Protection Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Pancreatic Beta-Cell Protection Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Pancreatic Beta-Cell Protection Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Pancreatic Beta-Cell Protection Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Pancreatic Beta-Cell Protection Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Pancreatic Beta-Cell Protection Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America Pancreatic Beta-Cell Protection Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America Pancreatic Beta-Cell Protection Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America Pancreatic Beta-Cell Protection Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America Pancreatic Beta-Cell Protection Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America Pancreatic Beta-Cell Protection Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America Pancreatic Beta-Cell Protection Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Pancreatic Beta-Cell Protection Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Pancreatic Beta-Cell Protection Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Pancreatic Beta-Cell Protection Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Pancreatic Beta-Cell Protection Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Pancreatic Beta-Cell Protection Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Pancreatic Beta-Cell Protection Market Size by Country (2023-2028) & (US$ Million)
    Table 64. ViaCyte Company Details
    Table 65. ViaCyte Business Overview
    Table 66. ViaCyte Pancreatic Beta-Cell Protection Product
    Table 67. ViaCyte Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
    Table 68. ViaCyte Recent Developments
    Table 69. PharmaCyte Biotech Company Details
    Table 70. PharmaCyte Biotech Business Overview
    Table 71. PharmaCyte Biotech Pancreatic Beta-Cell Protection Product
    Table 72. PharmaCyte Biotech Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
    Table 73. PharmaCyte Biotech Recent Developments
    Table 74. Boehringer Ingelheim Company Details
    Table 75. Boehringer Ingelheim Business Overview
    Table 76. Boehringer Ingelheim Pancreatic Beta-Cell Protection Product
    Table 77. Boehringer Ingelheim Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
    Table 78. Boehringer Ingelheim Recent Developments
    Table 79. GalaxoSmithKline Company Details
    Table 80. GalaxoSmithKline Business Overview
    Table 81. GalaxoSmithKline Pancreatic Beta-Cell Protection Product
    Table 82. GalaxoSmithKline Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
    Table 83. GalaxoSmithKline Recent Developments
    Table 84. Beta-Cell NV Company Details
    Table 85. Beta-Cell NV Business Overview
    Table 86. Beta-Cell NV Pancreatic Beta-Cell Protection Product
    Table 87. Beta-Cell NV Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
    Table 88. Beta-Cell NV Recent Developments
    Table 89. Novartis Company Details
    Table 90. Novartis Business Overview
    Table 91. Novartis Pancreatic Beta-Cell Protection Product
    Table 92. Novartis Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
    Table 93. Novartis Recent Developments
    Table 94. Janssen Research & Development Company Details
    Table 95. Janssen Research & Development Business Overview
    Table 96. Janssen Research & Development Pancreatic Beta-Cell Protection Product
    Table 97. Janssen Research & Development Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
    Table 98. Janssen Research & Development Recent Developments
    Table 99. Pfizer Inc Company Details
    Table 100. Pfizer Inc Business Overview
    Table 101. Pfizer Inc Pancreatic Beta-Cell Protection Product
    Table 102. Pfizer Inc Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
    Table 103. Pfizer Inc Recent Developments
    Table 104. BioLineRx Company Details
    Table 105. BioLineRx Business Overview
    Table 106. BioLineRx Pancreatic Beta-Cell Protection Product
    Table 107. BioLineRx Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
    Table 108. BioLineRx Recent Developments
    Table 109. Genentech Company Details
    Table 110. Genentech Business Overview
    Table 111. Genentech Pancreatic Beta-Cell Protection Product
    Table 112. Genentech Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
    Table 113. Genentech Recent Developments
    Table 114. Novo Nordisk Company Details
    Table 115. Novo Nordisk Business Overview
    Table 116. Novo Nordisk Pancreatic Beta-Cell Protection Product
    Table 117. Novo Nordisk Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
    Table 118. Novo Nordisk Recent Developments
    Table 119. Sanofi Company Details
    Table 120. Sanofi Business Overview
    Table 121. Sanofi Pancreatic Beta-Cell Protection Product
    Table 122. Sanofi Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
    Table 123. Sanofi Recent Developments
    Table 124. Osiris Therapeutics Company Details
    Table 125. Osiris Therapeutics Business Overview
    Table 126. Osiris Therapeutics Pancreatic Beta-Cell Protection Product
    Table 127. Osiris Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
    Table 128. Osiris Therapeutics Recent Developments
    Table 129. Beta-O2 Technologies Ltd Company Details
    Table 130. Beta-O2 Technologies Ltd Business Overview
    Table 131. Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Product
    Table 132. Beta-O2 Technologies Ltd Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
    Table 133. Beta-O2 Technologies Ltd Recent Developments
    Table 134. Transition Therapeutics Company Details
    Table 135. Transition Therapeutics Business Overview
    Table 136. Transition Therapeutics Pancreatic Beta-Cell Protection Product
    Table 137. Transition Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2017-2022) & (US$ Million)
    Table 138. Transition Therapeutics Recent Developments
    Table 139. Research Programs/Design for This Report
    Table 140. Key Data Information from Secondary Sources
    Table 141. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pancreatic Beta-Cell Protection Market Share by Type: 2021 VS 2028
    Figure 2. Stem Cell Based Features
    Figure 3. Gene Therapies Features
    Figure 4. RNA Based Therapies Features
    Figure 5. Monoclonal Antibodies (MAbs) Features
    Figure 6. Phytotherapy Features
    Figure 7. Global Pancreatic Beta-Cell Protection Market Share by Application: 2021 VS 2028
    Figure 8. Hospital Case Studies
    Figure 9. Medical Research Laboratory Case Studies
    Figure 10. Others Case Studies
    Figure 11. Pancreatic Beta-Cell Protection Report Years Considered
    Figure 12. Global Pancreatic Beta-Cell Protection Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Pancreatic Beta-Cell Protection Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Pancreatic Beta-Cell Protection Market Share by Region: 2021 VS 2028
    Figure 15. Global Pancreatic Beta-Cell Protection Market Share by Players in 2021
    Figure 16. Global Top Pancreatic Beta-Cell Protection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pancreatic Beta-Cell Protection as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Pancreatic Beta-Cell Protection Revenue in 2021
    Figure 18. North America Pancreatic Beta-Cell Protection Market Size YoY (2017-2028) & (US$ Million)
    Figure 19. North America Pancreatic Beta-Cell Protection Market Size Market Share by Type (2017-2028)
    Figure 20. North America Pancreatic Beta-Cell Protection Market Size Market Share by Application (2017-2028)
    Figure 21. North America Pancreatic Beta-Cell Protection Market Size Share by Country (2017-2028)
    Figure 22. United States Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Pancreatic Beta-Cell Protection Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Pancreatic Beta-Cell Protection Market Size Market Share by Type (2017-2028)
    Figure 26. Europe Pancreatic Beta-Cell Protection Market Size Market Share by Application (2017-2028)
    Figure 27. Europe Pancreatic Beta-Cell Protection Market Size Share by Country (2017-2028)
    Figure 28. Germany Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Pancreatic Beta-Cell Protection Market Size YoY (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Pancreatic Beta-Cell Protection Market Size Market Share by Type (2017-2028)
    Figure 36. Asia Pacific Pancreatic Beta-Cell Protection Market Size Market Share by Application (2017-2028)
    Figure 37. Asia Pacific Pancreatic Beta-Cell Protection Market Size Share by Region (2017-2028)
    Figure 38. China Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 44. Latin America Pancreatic Beta-Cell Protection Market Size YoY (2017-2028) & (US$ Million)
    Figure 45. Latin America Pancreatic Beta-Cell Protection Market Size Market Share by Type (2017-2028)
    Figure 46. Latin America Pancreatic Beta-Cell Protection Market Size Market Share by Application (2017-2028)
    Figure 47. Latin America Pancreatic Beta-Cell Protection Market Size Share by Country (2017-2028)
    Figure 48. Mexico Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Pancreatic Beta-Cell Protection Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Middle East and Africa Pancreatic Beta-Cell Protection Market Size Market Share by Type (2017-2028)
    Figure 52. Middle East and Africa Pancreatic Beta-Cell Protection Market Size Market Share by Application (2017-2028)
    Figure 53. Middle East and Africa Pancreatic Beta-Cell Protection Market Size Share by Country (2017-2028)
    Figure 54. Turkey Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. UAE Pancreatic Beta-Cell Protection Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. ViaCyte Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
    Figure 58. PharmaCyte Biotech Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
    Figure 59. Boehringer Ingelheim Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
    Figure 60. GalaxoSmithKline Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
    Figure 61. Beta-Cell NV Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
    Figure 62. Novartis Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
    Figure 63. Janssen Research & Development Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
    Figure 64. Pfizer Inc Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
    Figure 65. BioLineRx Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
    Figure 66. Genentech Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
    Figure 67. Novo Nordisk Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
    Figure 68. Sanofi Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
    Figure 69. Osiris Therapeutics Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
    Figure 70. Beta-O2 Technologies Ltd Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
    Figure 71. Transition Therapeutics Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2017-2022)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
ViaCyte
PharmaCyte Biotech
Boehringer Ingelheim
GalaxoSmithKline
Beta-Cell NV
Novartis
Janssen Research & Development
Pfizer Inc
BioLineRx
Genentech
Novo Nordisk
Sanofi
Osiris Therapeutics
Beta-O2 Technologies Ltd
Transition Therapeutics
Frequently Asked Questions
Pancreatic Beta-Cell Protection report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pancreatic Beta-Cell Protection report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pancreatic Beta-Cell Protection report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Woods Golf Shaft

Woods Golf Shaft market is segmented by Type and by Application. Players, stakeholders, and other ... Read More